117 related articles for article (PubMed ID: 16543679)
1. Comparison and problems of measured values of LH, FSH, and PRL among measurement systems.
Iwasa T; Matsuzaki T; Tanaka N; Minakuchi M; Shimizu F; Ogata R; Kiyokawa M; Maegawa M; Yasui T; Kuwahara A; Irahara M
Endocr J; 2006 Feb; 53(1):101-9. PubMed ID: 16543679
[TBL] [Abstract][Full Text] [Related]
2. Measurement Differences Between Two Immunoassay Systems for LH and FSH: A Comparison of Roche Cobas e601 vs. Abbott Architect i2000sr.
Yin L; Tang Y; Chen X; Sun Y
Clin Lab; 2018 Mar; 64(3):295-301. PubMed ID: 29739096
[TBL] [Abstract][Full Text] [Related]
3. Which hormone tests for the diagnosis of polycystic ovary syndrome?
Robinson S; Rodin DA; Deacon A; Wheeler MJ; Clayton RN
Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
[TBL] [Abstract][Full Text] [Related]
4. [Hyperprolactinemia and disorders of the menstrual cycle].
Topalski-Fistes N; Bujas M; Maticki-Sekulić M; Suvacarev S
Med Pregl; 1999; 52(3-5):156-61. PubMed ID: 10518402
[TBL] [Abstract][Full Text] [Related]
5. Compatible cut-off values for luteinizing hormone and the luteinizing hormone/follicle-stimulating hormone ratio in diagnostic criteria of the Japan Society of Obstetrics and Gynecology for polycystic ovary syndrome.
Yanagihara R; Matsuzaki T; Aoki H; Tamura K; Nagashima M; Minato S; Kamada S; Yamamoto Y; Irahara M; Iwasa T
J Obstet Gynaecol Res; 2023 Jan; 49(1):253-264. PubMed ID: 36307043
[TBL] [Abstract][Full Text] [Related]
6. Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.
Prelević GM; Würzburger MI; Perić LA
J Endocrinol Invest; 1988 Apr; 11(4):255-9. PubMed ID: 3137253
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
Prelević GM; Würzburger MI; Perić LA
J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
[TBL] [Abstract][Full Text] [Related]
9. Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome.
Venturoli S; Porcu E; Fabbri R; Magrini O; Gammi L; Paradisi R; Forcacci M; Bolzani R; Flamigni C
Clin Endocrinol (Oxf); 1988 Jan; 28(1):93-107. PubMed ID: 3139335
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia.
Su HW; Chen CM; Chou SY; Liang SJ; Hsu CS; Hsu MI
Gynecol Endocrinol; 2011 Jan; 27(1):55-62. PubMed ID: 20504100
[TBL] [Abstract][Full Text] [Related]
11. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
Li Y; Wei LN; Xiong YL; Liang XY
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
Tarlatzis BC; Grimbizis G; Pournaropoulos F; Bontis J; Lagos S; Spanos E; Mantalenakis S
Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
[TBL] [Abstract][Full Text] [Related]
13. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
van der Westhuizen S; van der Spuy ZM
Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
[TBL] [Abstract][Full Text] [Related]
14. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
15. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin evaluation in the diagnosis of polycystic ovary syndrome using either a monoclonal or a polyclonal antibody radioimmunoassay.
Manieri C; Pastorino R; Marolda AR; Musso MC; Gellona A; Barberis A; Boggio G; Messina M
J Endocrinol Invest; 1992 Mar; 15(3):219-22. PubMed ID: 1624683
[TBL] [Abstract][Full Text] [Related]
17. The hyperprolactinemic polycystic ovary syndrome may not be an distinct entity.
Corenblum B; Taylor PJ
Fertil Steril; 1982 Nov; 38(5):549-52. PubMed ID: 6813147
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
19. Interpretations of five monoclonal immunoassays of lutropin and follitropin: effects of normalization with WHO standard.
Vermes I; Bonte HA; v d Sluijs Veer G; Schoemaker J
Clin Chem; 1991 Mar; 37(3):415-21. PubMed ID: 1900742
[TBL] [Abstract][Full Text] [Related]
20. The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome.
Cho LW; Jayagopal V; Kilpatrick ES; Holding S; Atkin SL
Ann Clin Biochem; 2006 May; 43(Pt 3):217-9. PubMed ID: 16704758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
